Quick Answer
FILANA THERAPEUTICS, INC. reported Diluted EPS of $1.88 per share (loss) for fiscal year 2025.
FILANA THERAPEUTICS, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.88 | -28.8% |
| 2024 | -$1.46 | +37.1% |
| 2023 | -$2.32 | -22.1% |
| 2022 | -$1.90 | -512.9% |
| 2015 | -$0.31 | -14.8% |
| 2014 | -$0.27 | -138.6% |
| 2013 | $0.70 | +975.0% |
| 2012 | -$0.08 | -33.3% |
| 2011 | -$0.06 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.22 | +62.1% | +76.1% |
| June 30, 2025 | -$0.92 | -807.7% | -91.7% |
| March 31, 2025 | -$0.48 | -11.6% | +17.2% |
| September 30, 2024 | -$0.58 | +4.9% | -546.2% |
| June 30, 2024 | $0.13 | +120.6% | +130.2% |
| March 31, 2024 | -$0.43 | +25.9% | +29.5% |
| September 30, 2023 | -$0.61 | — | +3.2% |
| June 30, 2023 | -$0.63 | -31.3% | -8.6% |
- FILANA THERAPEUTICS, INC. showed a decrease of -28.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2011–2025 period, FILANA THERAPEUTICS, INC.’s diluted eps has declined by 3033.3% (from $0.06 per share (loss) to $1.88 per share (loss)).
- The most recent figure is from FILANA THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: